Open AccessBreast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast
Author(s) -
Mintsje de Boer,
Flora E. van Leeuwen,
Michael Hauptmann,
Lucy Overbeek,
Jan Paul de Boer,
Nathalie J. Hijmering,
Arthur Sernee,
C.A.H. Klazen,
Marc B. I. Lobbes,
René R. W. J. van der Hulst,
Hinne A. Rakhorst,
Daphne de Jong
Publication year - 2018
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2017.4510
Subject(s) - medicine , breast implant , anaplastic large cell lymphoma , breast cancer , odds ratio , oncology , implant , lymphoma , surgery , cancer
Breast implants are among the most commonly used medical devices. Since 2008, the number of women with breast implants diagnosed with anaplastic large-cell lymphoma in the breast (breast-ALCL) has increased, and several reports have suggested an association between breast implants and risk of breast-ALCL. However, relative and absolute risks of breast-ALCL in women with implants are still unknown, precluding evidence-based counseling about implants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom